{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:25:19Z","timestamp":1791991519847,"version":"4.4.0"},"reference-count":214,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["mdconsult.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["PET Clinics"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.cpet.2014.06.002","type":"journal-article","created":{"date-parts":[[2014,8,7]],"date-time":"2014-08-07T18:45:46Z","timestamp":1407437146000},"page":"391-420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["[18F]Fluorodeoxyglucose PET in Thoracic Malignancies"],"prefix":"10.1016","volume":"9","author":[{"given":"Mie Holm","family":"Vilstrup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew A.","family":"Torigian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cpet.2014.06.002_bib1","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1148\/radiol.2462070712","article-title":"Fleischner Society: glossary of terms for thoracic imaging","volume":"246","author":"Hansell","year":"2008","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.cpet.2014.06.002_bib2","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.1097\/RTI.0b013e31827657c8","article-title":"ACR\u00a0Appropriateness Criteria(R) radiographically detected solitary pulmonary nodule","volume":"28","author":"Kanne","year":"2013","journal-title":"J\u00a0Thorac Imaging"},{"issue":"7","key":"10.1016\/j.cpet.2014.06.002_bib3","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.285.7.914","article-title":"Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis","volume":"285","author":"Gould","year":"2001","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.cpet.2014.06.002_bib4","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1148\/radiol.2463062148","article-title":"Solitary pulmonary nodules: meta-analytic comparison of cross-sectional imaging modalities for diagnosis of malignancy","volume":"246","author":"Cronin","year":"2008","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.cpet.2014.06.002_bib5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2967\/jnumed.107.044990","article-title":"A\u00a0comparison of the diagnostic accuracy of 18F-FDG PET and CT in the characterization of solitary pulmonary nodules","volume":"49","author":"Fletcher","year":"2008","journal-title":"J\u00a0Nucl Med"},{"issue":"10","key":"10.1016\/j.cpet.2014.06.002_bib6","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s12149-011-0528-5","article-title":"Additional effects of FDG-PET to thin-section CT for the differential diagnosis of lung nodules: a Japanese multicenter clinical study","volume":"25","author":"Kubota","year":"2011","journal-title":"Ann Nucl Med"},{"issue":"2","key":"10.1016\/j.cpet.2014.06.002_bib7","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.lungcan.2007.12.021","article-title":"Efficacy of PET\/CT in the characterization of solid or partly solid solitary pulmonary nodules","volume":"61","author":"Jeong","year":"2008","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.cpet.2014.06.002_bib8","first-page":"443","article-title":"Tissue characterization of solitary pulmonary nodule: comparative study between helical dynamic CT and integrated PET\/CT","volume":"47","author":"Yi","year":"2006","journal-title":"J\u00a0Nucl Med"},{"issue":"11","key":"10.1016\/j.cpet.2014.06.002_bib9","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1002\/cncr.23928","article-title":"Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D-glucose avidity on positron emission tomography\/computed tomography","volume":"113","author":"Bar-Shalom","year":"2008","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.cpet.2014.06.002_bib10","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s00259-009-1061-9","article-title":"The value of FDG-PET\/CT in assessing single pulmonary nodules in patients at high risk of lung cancer","volume":"36","author":"Kagna","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.cpet.2014.06.002_bib11","first-page":"214","article-title":"Accuracy of PET\/CT in characterization of solitary pulmonary lesions","volume":"48","author":"Kim","year":"2007","journal-title":"J\u00a0Nucl Med"},{"issue":"1","key":"10.1016\/j.cpet.2014.06.002_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.lungcan.2004.01.009","article-title":"Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images","volume":"45","author":"Nomori","year":"2004","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.cpet.2014.06.002_bib13","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.lungcan.2008.11.015","article-title":"Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: the feasibility of integrated (18)F-FDG PET\/CT","volume":"65","author":"Chun","year":"2009","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.cpet.2014.06.002_bib14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0169-5002(02)00221-0","article-title":"PET imaging in patients with bronchioloalveolar cell carcinoma","volume":"38","author":"Heyneman","year":"2002","journal-title":"Lung Cancer"},{"issue":"9","key":"10.1016\/j.cpet.2014.06.002_bib15","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1007\/s00259-002-0853-y","article-title":"FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma?","volume":"29","author":"Yap","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.cpet.2014.06.002_bib16","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.lungcan.2008.11.009","article-title":"Mucinous versus\u00a0nonmucinous solitary pulmonary nodular bronchioloalveolar carcinoma: CT and FDG PET findings and pathologic comparisons","volume":"65","author":"Lee","year":"2009","journal-title":"Lung Cancer"},{"issue":"5","key":"10.1016\/j.cpet.2014.06.002_bib17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s12149-010-0358-x","article-title":"FDG-PET\/CT imaging in assessing mucin-producing non-small cell lung cancer with pathologic correlation","volume":"24","author":"Shim","year":"2010","journal-title":"Ann Nucl Med"},{"issue":"4","key":"10.1016\/j.cpet.2014.06.002_bib18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11604-009-0414-4","article-title":"Localized mucinous bronchioloalveolar carcinoma of the lung: thin-section computed tomography and fluorodeoxyglucose positron emission tomography findings","volume":"28","author":"Sawada","year":"2010","journal-title":"Jpn J Radiol"},{"issue":"5","key":"10.1016\/j.cpet.2014.06.002_bib19","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2214\/AJR.06.0503","article-title":"Integrated PET\/CT of pulmonary neuroendocrine tumors: diagnostic and prognostic implications","volume":"188","author":"Chong","year":"2007","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.cpet.2014.06.002_bib20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1378\/chest.06-0711","article-title":"The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules","volume":"131","author":"Daniels","year":"2007","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.cpet.2014.06.002_bib21","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jtcvs.2006.06.033","article-title":"Tumor fluoro-2-deoxy-D-glucose avidity on positron emission tomographic scan predicts mortality in patients with early-stage pure and mixed bronchioloalveolar carcinoma","volume":"132","author":"Raz","year":"2006","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"6","key":"10.1016\/j.cpet.2014.06.002_bib22","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.jtcvs.2007.02.023","article-title":"Associations among bronchioloalveolar carcinoma components, positron emission tomographic and computed tomographic findings, and malignant behavior in small lung adenocarcinomas","volume":"133","author":"Okada","year":"2007","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"3","key":"10.1016\/j.cpet.2014.06.002_bib23","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.lungcan.2009.02.011","article-title":"Lung adenocarcinoma as a solitary pulmonary nodule: prognostic determinants of CT, PET, and histopathologic findings","volume":"66","author":"Lee","year":"2009","journal-title":"Lung Cancer"},{"issue":"7","key":"10.1016\/j.cpet.2014.06.002_bib24","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/jjco\/hyl043","article-title":"[F-18]Fluorodeoxyglucose positron emission tomography can predict pathological tumor stage and proliferative activity determined by Ki-67 in clinical stage IA lung adenocarcinomas","volume":"36","author":"Watanabe","year":"2006","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"10.1016\/j.cpet.2014.06.002_bib25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1510\/icvts.2009.202580","article-title":"The maximum standardized uptake values on positron emission tomography to predict the Noguchi classification and invasiveness in clinical stage IA adenocarcinoma measuring 2 cm or less in size","volume":"9","author":"Maeda","year":"2009","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"9","key":"10.1016\/j.cpet.2014.06.002_bib26","first-page":"598","article-title":"Dual time-point FDG PET-CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area","volume":"100","author":"Sathekge","year":"2010","journal-title":"S\u00a0Afr Med J"},{"issue":"1","key":"10.1016\/j.cpet.2014.06.002_bib27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/RTI.0b013e31827882a9","article-title":"Nononcological applications of positron emission tomography for evaluation of the thorax","volume":"28","author":"Kwee","year":"2013","journal-title":"J\u00a0Thorac Imaging"},{"issue":"9","key":"10.1016\/j.cpet.2014.06.002_bib28","doi-asserted-by":"crossref","first-page":"724","DOI":"10.7326\/0003-4819-138-9-200305060-00009","article-title":"Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules","volume":"138","author":"Gould","year":"2003","journal-title":"Ann Intern Med"},{"issue":"Suppl 5","key":"10.1016\/j.cpet.2014.06.002_bib29","doi-asserted-by":"crossref","first-page":"e93S","DOI":"10.1378\/chest.12-2351","article-title":"Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Gould","year":"2013","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.cpet.2014.06.002_bib30","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1148\/radiol.2372041887","article-title":"Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society","volume":"237","author":"MacMahon","year":"2005","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.cpet.2014.06.002_bib31","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1148\/radiol.12120628","article-title":"Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society","volume":"266","author":"Naidich","year":"2013","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.cpet.2014.06.002_bib32","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2967\/jnumed.107.047787","article-title":"Recommendations on the use of 18F-FDG PET in oncology","volume":"49","author":"Fletcher","year":"2008","journal-title":"J\u00a0Nucl Med"},{"issue":"4","key":"10.1016\/j.cpet.2014.06.002_bib33","doi-asserted-by":"crossref","first-page":"W107","DOI":"10.1097\/RTI.0b013e3181f51e7f","article-title":"ACR Appropriateness Criteria(R) noninvasive clinical staging of bronchogenic carcinoma","volume":"25","author":"Ravenel","year":"2010","journal-title":"J\u00a0Thorac Imaging"},{"issue":"6","key":"10.1016\/j.cpet.2014.06.002_bib34","doi-asserted-by":"crossref","first-page":"645","DOI":"10.6004\/jnccn.2013.0084","article-title":"Non-small cell lung cancer, version 2.2013","volume":"11","author":"Ettinger","year":"2013","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"Suppl 5","key":"10.1016\/j.cpet.2014.06.002_bib35","doi-asserted-by":"crossref","first-page":"e211S","DOI":"10.1378\/chest.12-2355","article-title":"Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Silvestri","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.cpet.2014.06.002_bib36","unstructured":"The diagnosis and treatment of lung cancer (update). NICE clinical guideline. 121,2011;1\u2013173. Available at: www.nice.org.uk\/guidance\/cg121."},{"key":"10.1016\/j.cpet.2014.06.002_bib37","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/1472-6963-10-283","article-title":"A\u00a0systematic review of PET and PET\/CT in oncology: a way to personalize cancer treatment in a cost-effective manner?","volume":"10","author":"Langer","year":"2010","journal-title":"BMC Health Serv Res"},{"issue":"11","key":"10.1016\/j.cpet.2014.06.002_bib38","doi-asserted-by":"crossref","first-page":"879","DOI":"10.7326\/0003-4819-139-11-200311180-00013","article-title":"Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis","volume":"139","author":"Gould","year":"2003","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.cpet.2014.06.002_bib39","doi-asserted-by":"crossref","first-page":"E37","DOI":"10.1002\/ijc.27779","article-title":"Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography\/computed tomography for the detection of metastases in non-small-cell lung cancer patients","volume":"132","author":"Wu","year":"2013","journal-title":"Int J Cancer"},{"issue":"8","key":"10.1016\/j.cpet.2014.06.002_bib40","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1097\/JTO.0b013e31821d4384","article-title":"Diagnostic performance of integrated positron emission tomography\/computed tomography for mediastinal lymph node staging in non-small cell lung cancer: a bivariate systematic review and meta-analysis","volume":"6","author":"Lv","year":"2011","journal-title":"J\u00a0Thorac Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.cpet.2014.06.002_bib41","doi-asserted-by":"crossref","first-page":"137S","DOI":"10.1378\/chest.123.1_suppl.137S","article-title":"Noninvasive staging of non-small cell lung cancer: a review of the current evidence","volume":"123","author":"Toloza","year":"2003","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.cpet.2014.06.002_bib42","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s12149-011-0529-4","article-title":"Additional value of FDG-PET to contrast enhanced-computed tomography (CT) for the diagnosis of mediastinal lymph node metastasis in non-small cell lung cancer: a Japanese multicenter clinical study","volume":"25","author":"Kubota","year":"2011","journal-title":"Ann Nucl Med"},{"issue":"1","key":"10.1016\/j.cpet.2014.06.002_bib43","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/ejcts\/ezr287","article-title":"Lymph node metastasis diagnosis using positron emission tomography with 2-[18F] fluoro-2-deoxy-D-glucose as a tracer and computed tomography in surgical cases of non-small cell lung cancer","volume":"42","author":"Ose","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"issue":"1","key":"10.1016\/j.cpet.2014.06.002_bib44","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.athoracsur.2007.03.081","article-title":"Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer","volume":"84","author":"Lee","year":"2007","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"10.1016\/j.cpet.2014.06.002_bib45","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.lungcan.2013.04.012","article-title":"Risk factors for predicting the occult nodal metastasis in T1-2N0M0 NSCLC patients staged by PET\/CT: potential value in the clinic","volume":"81","author":"Li","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cpet.2014.06.002_bib46","article-title":"Prognostic value of primary tumor FDG uptake for occult mediastinal lymph node involvement in clinically N2\/N3 Node-negative non-small cell lung cancer","author":"Trister","year":"2012","journal-title":"Am J Clin Oncol"},{"issue":"10","key":"10.1016\/j.cpet.2014.06.002_bib47","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1007\/s12149-011-0530-y","article-title":"The value of (1)(8)F-FDG-PET\/CT in the differential diagnosis of solitary pulmonary nodules in areas with a high incidence of tuberculosis","volume":"25","author":"Li","year":"2011","journal-title":"Ann Nucl Med"},{"issue":"1","key":"10.1016\/j.cpet.2014.06.002_bib48","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejcts.2005.10.002","article-title":"The size of mediastinal lymph nodes and its relation with metastatic involvement: a meta-analysis","volume":"29","author":"de Langen","year":"2006","journal-title":"Eur J Cardiothorac Surg"},{"issue":"4","key":"10.1016\/j.cpet.2014.06.002_bib49","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJM200007273430404","article-title":"Preoperative staging of non-small-cell lung cancer with positron-emission tomography","volume":"343","author":"Pieterman","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.cpet.2014.06.002_bib50","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.2967\/jnumed.108.056713","article-title":"Relationship between cancer type and impact of PET and PET\/CT on intended management: findings of the national oncologic PET registry","volume":"49","author":"Hillner","year":"2008","journal-title":"J\u00a0Nucl Med"},{"issue":"3","key":"10.1016\/j.cpet.2014.06.002_bib51","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2967\/jnumed.113.124230","article-title":"Preoperative PET and the reduction of unnecessary surgery among newly diagnosed lung cancer patients in a community setting","volume":"55","author":"Zeliadt","year":"2014","journal-title":"J\u00a0Nucl Med"},{"issue":"5","key":"10.1016\/j.cpet.2014.06.002_bib52","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1007\/s00259-013-2672-8","article-title":"Impact of initial PET\/CT staging in terms of clinical stage, management plan, and prognosis in 592 patients with non-small-cell lung cancer","volume":"41","author":"Takeuchi","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.cpet.2014.06.002_bib53","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.suronc.2013.04.001","article-title":"Meta-analysis: accuracy of 18FDG PET-CT for distant metastasis staging in lung cancer patients","volume":"22","author":"Li","year":"2013","journal-title":"Surg Oncol"},{"issue":"2","key":"10.1016\/j.cpet.2014.06.002_bib54","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4149\/neo_2010_02_129","article-title":"18F-FDG PET\/CT in the evaluation of adrenal masses in lung cancer patients","volume":"57","author":"Lu","year":"2010","journal-title":"Neoplasma"},{"issue":"12","key":"10.1016\/j.cpet.2014.06.002_bib55","first-page":"2058","article-title":"18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer","volume":"45","author":"Kumar","year":"2004","journal-title":"J\u00a0Nucl Med"},{"issue":"5","key":"10.1016\/j.cpet.2014.06.002_bib56","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.clon.2010.10.002","article-title":"Fluorine-18 deoxyglucose positron emission tomography, magnetic resonance imaging and bone scintigraphy for the diagnosis of bone metastases in patients with lung cancer: which one is the best?\u2013a meta-analysis","volume":"23","author":"Liu","year":"2011","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"5","key":"10.1016\/j.cpet.2014.06.002_bib57","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.ejrad.2011.01.126","article-title":"A\u00a0meta-analysis of (1)(8)FDG-PET-CT, (1)(8)FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer","volume":"81","author":"Qu","year":"2012","journal-title":"Eur J Radiol"},{"issue":"3","key":"10.1016\/j.cpet.2014.06.002_bib58","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3413\/Nukmed-0338-10-07","article-title":"Brain metastasis in lung cancer. Comparison of cerebral MRI and 18F-FDG-PET\/CT for diagnosis in the initial staging","volume":"50","author":"Kruger","year":"2011","journal-title":"Nuklearmedizin"},{"issue":"6","key":"10.1016\/j.cpet.2014.06.002_bib59","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.3346\/jkms.2009.24.6.1132","article-title":"Diagnostic efficacy of PET\/CT plus brain MR imaging for detection of extrathoracic metastases in patients with lung adenocarcinoma","volume":"24","author":"Lee","year":"2009","journal-title":"J\u00a0Korean Med Sci"},{"issue":"1","key":"10.1016\/j.cpet.2014.06.002_bib60","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1148\/radiol.13121038","article-title":"PET\/MR imaging: technical aspects and potential clinical applications","volume":"267","author":"Torigian","year":"2013","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.cpet.2014.06.002_bib61","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2967\/jnumed.113.129825","article-title":"Thoracic staging in lung cancer: prospective comparison of 18F-FDG PET\/MRI and 18F-FDG PET\/CT","volume":"55","author":"Heusch","year":"2014","journal-title":"J\u00a0Nucl Med"},{"issue":"5","key":"10.1016\/j.cpet.2014.06.002_bib62","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1245\/s10434-012-2799-z","article-title":"Advantages of diffusion-weighted imaging over positron emission tomography-computed tomography in assessment of hilar and mediastinal lymph node in lung cancer","volume":"20","author":"Usuda","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.cpet.2014.06.002_bib63","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s00330-012-2388-3","article-title":"A\u00a0proposal for combined MRI and PET\/CT interpretation criteria for preoperative nodal staging in non-small-cell lung cancer","volume":"22","author":"Kim","year":"2012","journal-title":"Eur Radiol"},{"issue":"11","key":"10.1016\/j.cpet.2014.06.002_bib64","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1007\/s00330-013-2914-y","article-title":"N\u00a0staging of lung cancer patients with PET\/MRI using a three-segment model attenuation correction algorithm: initial experience","volume":"23","author":"Kohan","year":"2013","journal-title":"Eur Radiol"},{"issue":"14","key":"10.1016\/j.cpet.2014.06.002_bib65","first-page":"1951","article-title":"Virtual bronchoscopy using FDG-PET\/CT images for the evaluation of lung cancer","volume":"16","author":"Yildirim","year":"2012","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"5","key":"10.1016\/j.cpet.2014.06.002_bib66","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/JTO.0b013e3181d0a4f5","volume":"5","author":"Paesmans","year":"2010","journal-title":"J\u00a0Thorac Oncol"},{"issue":"6","key":"10.1016\/j.cpet.2014.06.002_bib67","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.athoracsur.2013.06.086","article-title":"Prognostic role of positron emission tomography and high-resolution computed tomography in clinical stage IA lung adenocarcinoma","volume":"96","author":"Uehara","year":"2013","journal-title":"Ann Thorac Surg"},{"issue":"11","key":"10.1016\/j.cpet.2014.06.002_bib68","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1245\/s10434-012-2414-3","article-title":"FDG-PET SUVmax combined with IASLC\/ATS\/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma","volume":"19","author":"Kadota","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.cpet.2014.06.002_bib69","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00432-014-1591-9","article-title":"High FDG uptake predicts poorer survival in locally advanced nonsmall cell lung cancer patients undergoing curative radiotherapy, independently of tumor size","volume":"140","author":"Ulger","year":"2014","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"2","key":"10.1016\/j.cpet.2014.06.002_bib70","first-page":"805","article-title":"Use of maximum standardized uptake value on fluorodeoxyglucose positron-emission tomography in predicting lymph node involvement in patients with primary non-small cell lung cancer","volume":"34","author":"Muto","year":"2014","journal-title":"Anticancer Res"},{"issue":"8","key":"10.1016\/j.cpet.2014.06.002_bib71","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s12149-011-0502-2","article-title":"18F-FDG uptake in primary lung cancer as a predictor of intratumoral vessel invasion","volume":"25","author":"Ishibashi","year":"2011","journal-title":"Ann Nucl Med"},{"issue":"1","key":"10.1016\/j.cpet.2014.06.002_bib72","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00432-013-1545-7","article-title":"FDG PET\/CT metabolic tumor volume and total lesion glycolysis predict prognosis in patients with advanced lung adenocarcinoma","volume":"140","author":"Chung","year":"2014","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.cpet.2014.06.002_bib73","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.acra.2012.07.002","article-title":"Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer","volume":"20","author":"Zhang","year":"2013","journal-title":"Acad Radiol"},{"issue":"1","key":"10.1016\/j.cpet.2014.06.002_bib74","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cllc.2011.05.001","article-title":"Metabolic tumor volume is an independent prognostic factor in patients treated definitively for non-small-cell lung cancer","volume":"13","author":"Lee","year":"2012","journal-title":"Clin Lung Cancer"},{"issue":"2","key":"10.1016\/j.cpet.2014.06.002_bib75","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1148\/radiol.12111148","article-title":"Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET\/CT in non-small cell lung cancer","volume":"264","author":"Chen","year":"2012","journal-title":"Radiology"},{"issue":"8","key":"10.1016\/j.cpet.2014.06.002_bib76","first-page":"1308","article-title":"The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification?","volume":"35","author":"Hamberg","year":"1994","journal-title":"J\u00a0Nucl Med"},{"issue":"9","key":"10.1016\/j.cpet.2014.06.002_bib77","first-page":"1412","article-title":"Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes","volume":"42","author":"Zhuang","year":"2001","journal-title":"J\u00a0Nucl Med"},{"issue":"1","key":"10.1016\/j.cpet.2014.06.002_bib78","first-page":"9","article-title":"Temporal profile of fluorodeoxyglucose uptake in malignant lesions and normal organs over extended time periods in patients with lung carcinoma: implications for its utilization in assessing malignant lesions","volume":"53","author":"Basu","year":"2009","journal-title":"Q\u00a0J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.cpet.2014.06.002_bib79","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/RLU.0000000000000313","article-title":"Serial changes of FDG uptake and diagnosis of suspected lung malignancy: a lesion-based analysis","volume":"39","author":"Cheng","year":"2014","journal-title":"Clin Nucl Med"},{"issue":"4","key":"10.1016\/j.cpet.2014.06.002_bib80","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s12149-013-0698-4","article-title":"Assessment of FDG retention differences between the FDG-avid benign pulmonary lesion and primary lung cancer using dual-time-point FDG-PET imaging","volume":"27","author":"Kaneko","year":"2013","journal-title":"Ann Nucl Med"},{"issue":"5","key":"10.1016\/j.cpet.2014.06.002_bib81","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/MAJ.0b013e31827b9b6d","article-title":"Dual time point positron emission tomography\/computed tomography scan in evaluation of intrathoracic lesions in an area endemic for histoplasmosis and with high prevalence of sarcoidosis","volume":"346","author":"Kadaria","year":"2013","journal-title":"Am J Med Sci"},{"issue":"10","key":"10.1016\/j.cpet.2014.06.002_bib82","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/MNM.0b013e32835710d6","article-title":"Potential value of dual-time-point (1)(8)F-FDG PET compared with initial single-time-point imaging in differentiating malignant from benign pulmonary nodules: a systematic review and meta-analysis","volume":"33","author":"Lin","year":"2012","journal-title":"Nucl Med Commun"},{"issue":"2","key":"10.1016\/j.cpet.2014.06.002_bib83","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.acra.2011.10.009","article-title":"Diagnostic performance of dual-time 18F-FDG PET in the diagnosis of pulmonary nodules: a meta-analysis","volume":"19","author":"Barger","year":"2012","journal-title":"Acad Radiol"},{"issue":"7","key":"10.1016\/j.cpet.2014.06.002_bib84","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1177\/0284185113481594","article-title":"Dual time point 18FDG-PET\/CT versus single time point 18FDG-PET\/CT for the differential diagnosis of pulmonary nodules: a meta-analysis","volume":"54","author":"Zhang","year":"2013","journal-title":"Acta Radiol"},{"issue":"6","key":"10.1016\/j.cpet.2014.06.002_bib85","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/RLU.0b013e3182173810","article-title":"Value of dual-time-point FDG PET\/CT for mediastinal nodal staging in non-small-cell lung cancer patients with lung comorbidity","volume":"36","author":"Hu","year":"2011","journal-title":"Clin Nucl Med"},{"issue":"6","key":"10.1016\/j.cpet.2014.06.002_bib86","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/RLU.0b013e3182173823","article-title":"Impact of dual-time-point F-18 FDG PET\/CT in the assessment of pleural effusion in patients with non-small-cell lung cancer","volume":"36","author":"Alkhawaldeh","year":"2011","journal-title":"Clin Nucl Med"},{"issue":"4","key":"10.1016\/j.cpet.2014.06.002_bib87","first-page":"540","article-title":"18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax","volume":"44","author":"Demura","year":"2003","journal-title":"J\u00a0Nucl Med"},{"issue":"10","key":"10.1016\/j.cpet.2014.06.002_bib88","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.2967\/jnumed.108.051250","article-title":"Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer","volume":"49","author":"Uesaka","year":"2008","journal-title":"J\u00a0Nucl Med"},{"issue":"6","key":"10.1016\/j.cpet.2014.06.002_bib89","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/RLU.0b013e31820adef8","article-title":"Limited predictive value of dual-time-point F-18 FDG PET\/CT for evaluation of pathologic N1 status in NSCLC patients","volume":"36","author":"Kim","year":"2011","journal-title":"Clin Nucl Med"},{"issue":"7","key":"10.1016\/j.cpet.2014.06.002_bib90","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s00259-008-0733-1","article-title":"18F-FDG PET for the lymph node staging of non-small cell lung cancer in a tuberculosis-endemic country: is dual time point imaging worth the effort?","volume":"35","author":"Yen","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"10.1016\/j.cpet.2014.06.002_bib91","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/j.ejrad.2011.03.074","article-title":"Regional nodal staging with 18F-FDG PET-CT in non-small cell lung cancer: additional diagnostic value of CT attenuation and dual-time-point imaging","volume":"81","author":"Li","year":"2012","journal-title":"Eur J Radiol"},{"issue":"2","key":"10.1016\/j.cpet.2014.06.002_bib92","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ejrad.2009.04.044","article-title":"Dual-time point scanning of integrated FDG PET\/CT for the evaluation of mediastinal and hilar lymph nodes in non-small cell lung cancer diagnosed as operable by contrast-enhanced CT","volume":"75","author":"Kasai","year":"2010","journal-title":"Eur J Radiol"},{"issue":"3","key":"10.1016\/j.cpet.2014.06.002_bib93","first-page":"224","article-title":"Differentiation of histological subtypes in lung cancer with 18F-FDG-PET 3-point imaging and kinetic analysis","volume":"14","author":"Tsuchida","year":"2011","journal-title":"Hell J Nucl Med"},{"issue":"10","key":"10.1016\/j.cpet.2014.06.002_bib94","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1007\/s00259-013-2452-5","article-title":"The increment in standardized uptake value determined using dual-phase 18F-FDG PET is a promising prognostic factor in non-small-cell lung cancer","volume":"40","author":"Chen","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/j.cpet.2014.06.002_bib95","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2967\/jnumed.109.068643","article-title":"Prognostic implication of dual-phase PET in adenocarcinoma of the lung","volume":"51","author":"Houseni","year":"2010","journal-title":"J\u00a0Nucl Med"},{"issue":"11","key":"10.1016\/j.cpet.2014.06.002_bib96","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1016\/j.ejrad.2011.11.047","article-title":"Value of dual time point F-18 FDG-PET\/CT imaging for the evaluation of prognosis and risk factors for recurrence in patients with stage I non-small cell lung cancer treated with stereotactic body radiation therapy","volume":"81","author":"Satoh","year":"2012","journal-title":"Eur J Radiol"},{"issue":"1","key":"10.1016\/j.cpet.2014.06.002_bib97","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.radonc.2010.11.007","article-title":"Limited prognostic value of dual time point F-18 FDG PET\/CT in patients with early stage (stage I & II) non-small cell lung cancer (NSCLC)","volume":"98","author":"Kim","year":"2011","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.cpet.2014.06.002_bib98","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/1097-0142(20010815)92:4<886::AID-CNCR1397>3.0.CO;2-V","article-title":"F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high impact on treatment","volume":"92","author":"Mac Manus","year":"2001","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.cpet.2014.06.002_bib99","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.ijrobp.2010.04.018","article-title":"Impact of [18F]fluorodeoxyglucose PET-CT staging on treatment planning in radiotherapy incorporating elective nodal irradiation for non-small-cell lung cancer: a prospective study","volume":"80","author":"Kolodziejczyk","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.cpet.2014.06.002_bib100","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ijrobp.2010.09.033","article-title":"A\u00a0phase II comparative study of gross tumor volume definition with or without PET\/CT fusion in dosimetric planning for non-small-cell lung cancer (NSCLC): primary analysis of Radiation Therapy Oncology Group (RTOG) 0515","volume":"82","author":"Bradley","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.cpet.2014.06.002_bib101","first-page":"191","article-title":"The impact of PET and PET\/CT on treatment planning and prognosis of patients with NSCLC treated with radiation therapy","volume":"56","author":"Nawara","year":"2012","journal-title":"Q\u00a0J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.cpet.2014.06.002_bib102","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1148\/radiol.13130652","article-title":"Volume-based parameters measured by using FDG PET\/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value","volume":"270","author":"Satoh","year":"2014","journal-title":"Radiology"},{"issue":"10","key":"10.1016\/j.cpet.2014.06.002_bib103","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/MNM.0b013e32836491a9","article-title":"Prognostic value of metabolic tumor volume and total lesion glycolysis from (1)(8)F-FDG PET\/CT in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer","volume":"34","author":"Vu","year":"2013","journal-title":"Nucl Med Commun"},{"issue":"2","key":"10.1016\/j.cpet.2014.06.002_bib104","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.radonc.2011.08.008","article-title":"The maximum standardized uptake value (SUVmax) on FDG-PET is a strong predictor of local recurrence for localized non-small-cell lung cancer after stereotactic body radiotherapy (SBRT)","volume":"101","author":"Takeda","year":"2011","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.cpet.2014.06.002_bib105","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ijrobp.2013.10.029","volume":"88","author":"Nair","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.cpet.2014.06.002_bib106","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1200\/JCO.2003.07.054","article-title":"Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer","volume":"21","author":"Mac Manus","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.cpet.2014.06.002_bib107","doi-asserted-by":"crossref","first-page":"31S","DOI":"10.2967\/jnumed.108.057216","article-title":"Role of 18F-FDG PET in assessment of response in non-small cell lung cancer","volume":"50","author":"Hicks","year":"2009","journal-title":"J\u00a0Nucl Med"},{"issue":"5","key":"10.1016\/j.cpet.2014.06.002_bib108","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.ijrobp.2010.04.021","article-title":"Association between pulmonary uptake of fluorodeoxyglucose detected by positron emission tomography scanning after radiation therapy for non-small-cell lung cancer and radiation pneumonitis","volume":"80","author":"Mac Manus","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.cpet.2014.06.002_bib109","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.ijrobp.2007.01.031","article-title":"Radiation pneumonitis: local dose versus [18F]-fluorodeoxyglucose uptake response in irradiated lung","volume":"68","author":"Guerrero","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.cpet.2014.06.002_bib110","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ijrobp.2010.06.016","article-title":"[(18)F]fluorodeoxyglucose uptake patterns in lung before radiotherapy identify areas more susceptible to radiation-induced lung toxicity in non-small-cell lung cancer patients","volume":"81","author":"Petit","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.cpet.2014.06.002_bib111","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.radonc.2012.04.019","article-title":"Stereotactic body radiotherapy (SBRT) for non-small cell lung cancer (NSCLC): is FDG-PET a predictor of outcome?","volume":"104","author":"Clarke","year":"2012","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.cpet.2014.06.002_bib112","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3816\/CLC.2008.n.032","article-title":"Fractionated stereotactic body radiation therapy in the treatment of primary, recurrent, and metastatic lung tumors: the role of positron emission tomography\/computed tomography-based treatment planning","volume":"9","author":"Coon","year":"2008","journal-title":"Clin Lung Cancer"},{"issue":"1","key":"10.1016\/j.cpet.2014.06.002_bib113","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.lungcan.2004.11.024","article-title":"Metabolic (FDG-PET) response after radical radiotherapy\/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure","volume":"49","author":"Mac Manus","year":"2005","journal-title":"Lung Cancer"},{"issue":"30","key":"10.1016\/j.cpet.2014.06.002_bib114","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1200\/JCO.2012.47.5947","article-title":"Prediction of survival by [18F]fluorodeoxyglucose positron emission tomography in patients with locally advanced non-small-cell lung cancer undergoing definitive chemoradiation therapy: results of the ACRIN 6668\/RTOG 0235 trial","volume":"31","author":"Machtay","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.cpet.2014.06.002_bib115","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ejca.2008.10.017","article-title":"Follow-up with 18FDG-PET-CT after radical radiotherapy with or without chemotherapy allows the detection of potentially curable progressive disease in non-small cell lung cancer patients: a prospective study","volume":"45","author":"van Loon","year":"2009","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.cpet.2014.06.002_bib116","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejca.2009.10.028","article-title":"18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: an economic evaluation","volume":"46","author":"van Loon","year":"2010","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.cpet.2014.06.002_bib117","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00280-013-2356-x","article-title":"Predictive and prognostic value of early response assessment using 18FDG-PET in advanced non-small cell lung cancer patients treated with erlotinib","volume":"73","author":"Tiseo","year":"2014","journal-title":"Cancer Chemother Pharmacol"},{"issue":"13","key":"10.1016\/j.cpet.2014.06.002_bib118","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1200\/JCO.2010.32.4939","article-title":"Early prediction of nonprogression in advanced non-small-cell lung cancer treated with erlotinib by using [(18)F]fluorodeoxyglucose and [(18)F]fluorothymidine positron emission tomography","volume":"29","author":"Zander","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.cpet.2014.06.002_bib119","doi-asserted-by":"crossref","first-page":"530","DOI":"10.2967\/jnumed.111.092544","article-title":"18F-FDG PET as a surrogate biomarker in non-small cell lung cancer treated with erlotinib: newly identified lesions are more informative than standardized uptake value","volume":"53","author":"Bengtsson","year":"2012","journal-title":"J\u00a0Nucl Med"},{"issue":"1","key":"10.1016\/j.cpet.2014.06.002_bib120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/MNM.0b013e3283599999","article-title":"18F-FDG-PET evaluation of pathological tumour response to neoadjuvant therapy in patients with NSCLC","volume":"34","author":"Zhang","year":"2013","journal-title":"Nucl Med Commun"},{"issue":"1","key":"10.1016\/j.cpet.2014.06.002_bib121","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00259-005-1919-4","article-title":"Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer","volume":"33","author":"Hellwig","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"10.1016\/j.cpet.2014.06.002_bib122","first-page":"1640","article-title":"PET\/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management","volume":"45","author":"Keidar","year":"2004","journal-title":"J\u00a0Nucl Med"},{"issue":"5","key":"10.1016\/j.cpet.2014.06.002_bib123","first-page":"408","article-title":"PET\/CT vs. non-contrast CT alone for surveillance 1-year post lobectomy for stage I non-small-cell lung cancer","volume":"3","author":"Dane","year":"2013","journal-title":"Am J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.cpet.2014.06.002_bib124","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/icvts\/ivs368","article-title":"18F-fluorodeoxyglucose positron emission tomography\/computed tomography is useful in postoperative follow-up of asymptomatic non-small-cell lung cancer patients","volume":"15","author":"Toba","year":"2012","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"3","key":"10.1016\/j.cpet.2014.06.002_bib125","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/0284185113498536","article-title":"Diagnostic efficacy of PET and PET\/CT for recurrent lung cancer: a meta-analysis","volume":"55","author":"He","year":"2014","journal-title":"Acta Radiol"},{"issue":"Suppl 5","key":"10.1016\/j.cpet.2014.06.002_bib126","doi-asserted-by":"crossref","first-page":"e437S","DOI":"10.1378\/chest.12-2365","article-title":"Follow-up and surveillance of the patient with lung cancer after curative-intent therapy: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Colt","year":"2013","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.cpet.2014.06.002_bib127","doi-asserted-by":"crossref","first-page":"78","DOI":"10.6004\/jnccn.2013.0011","article-title":"Small cell lung cancer","volume":"11","author":"Kalemkerian","year":"2013","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.cpet.2014.06.002_bib128","doi-asserted-by":"crossref","first-page":"99","DOI":"10.6004\/jnccn.2013.0012","article-title":"Modern staging of small cell lung cancer","volume":"11","author":"Kalemkerian","year":"2013","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"Suppl 5","key":"10.1016\/j.cpet.2014.06.002_bib129","doi-asserted-by":"crossref","first-page":"e400S","DOI":"10.1378\/chest.12-2363","article-title":"Treatment of small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Jett","year":"2013","journal-title":"Chest"},{"issue":"16","key":"10.1016\/j.cpet.2014.06.002_bib130","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1200\/JCO.2004.11.089","article-title":"Positron emission tomography in limited-stage small-cell lung cancer: a prospective study","volume":"22","author":"Bradley","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.cpet.2014.06.002_bib131","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1007\/s00259-004-1606-x","article-title":"Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer","volume":"31","author":"Brink","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.cpet.2014.06.002_bib132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-5002(01)00492-5","article-title":"Whole body FDG-PET for the evaluation and staging of small cell lung cancer: a preliminary study","volume":"37","author":"Chin","year":"2002","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.cpet.2014.06.002_bib133","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/01.coc.0000239095.09662.19","article-title":"Staging and monitoring of small cell lung cancer using [18F]fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)","volume":"30","author":"Kut","year":"2007","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"10.1016\/j.cpet.2014.06.002_bib134","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/annonc\/mdl374","article-title":"A\u00a0prospective study of PET\/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysis","volume":"18","author":"Fischer","year":"2007","journal-title":"Ann Oncol"},{"issue":"7\u20138","key":"10.1016\/j.cpet.2014.06.002_bib135","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1159\/000341073","article-title":"The role of integrated 18F-FDG PET-CT as a staging tool for limited-stage small cell lung cancer: a retrospective study","volume":"35","author":"Sohn","year":"2012","journal-title":"Onkologie"},{"issue":"1","key":"10.1016\/j.cpet.2014.06.002_bib136","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3816\/CLC.2008.n.005","article-title":"Can positron emission tomography be used as a staging tool for small-cell lung cancer?","volume":"9","author":"Vinjamuri","year":"2008","journal-title":"Clin Lung Cancer"},{"issue":"4","key":"10.1016\/j.cpet.2014.06.002_bib137","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s11307-009-0295-z","article-title":"High impact of 18F-FDG-PET on management and prognostic stratification of newly diagnosed small cell lung cancer","volume":"12","author":"Azad","year":"2010","journal-title":"Mol Imaging Biol"},{"issue":"4","key":"10.1016\/j.cpet.2014.06.002_bib138","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s002590100474","article-title":"FDG-PET imaging for the staging and follow-up of small cell lung cancer","volume":"28","author":"Schumacher","year":"2001","journal-title":"Eur J Nucl Med"},{"issue":"2B","key":"10.1016\/j.cpet.2014.06.002_bib139","first-page":"1257","article-title":"Whole-body 18F-2-deoxyglucose positron emission tomography in primary staging small cell lung cancer","volume":"22","author":"Shen","year":"2002","journal-title":"Anticancer Res"},{"issue":"2","key":"10.1016\/j.cpet.2014.06.002_bib140","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/01.coc.0000054889.58718.6F","article-title":"Impact of positron emission tomography on the management of patients with small-cell lung cancer: preliminary experience","volume":"27","author":"Blum","year":"2004","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"10.1016\/j.cpet.2014.06.002_bib141","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1378\/chest.119.3.950","article-title":"Positron emission tomography in the staging of small-cell lung cancer: a preliminary study","volume":"119","author":"Hauber","year":"2001","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.cpet.2014.06.002_bib142","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.lungcan.2007.04.001","article-title":"Detection of unsuspected distant metastases and\/or regional nodes by FDG-PET [corrected] scan in apparent limited-disease small-cell lung cancer","volume":"57","author":"Niho","year":"2007","journal-title":"Lung Cancer"},{"issue":"12","key":"10.1016\/j.cpet.2014.06.002_bib143","first-page":"1911","article-title":"Whole-body (18)F-FDG PET improves the management of patients with small cell lung cancer","volume":"44","author":"Kamel","year":"2003","journal-title":"J\u00a0Nucl Med"},{"issue":"1","key":"10.1016\/j.cpet.2014.06.002_bib144","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00259-002-0937-8","article-title":"Prognostic value of [18F]FDG-PET imaging in small cell lung cancer","volume":"30","author":"Pandit","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.cpet.2014.06.002_bib145","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.ijrobp.2012.10.003","article-title":"Total gross tumor volume is an independent prognostic factor in patients treated with selective nodal irradiation for stage I to III small cell lung cancer","volume":"85","author":"Reymen","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.cpet.2014.06.002_bib146","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00259-011-2059-7","article-title":"Whole-body metabolic tumour volume of 18F-FDG PET\/CT improves the prediction of prognosis in small cell lung cancer","volume":"39","author":"Oh","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.cpet.2014.06.002_bib147","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.lungcan.2011.01.007","article-title":"Prognostic significance of metabolic parameters measured by (18)F-fluorodeoxyglucose positron emission tomography\/computed tomography in patients with small cell lung cancer","volume":"73","author":"Zhu","year":"2011","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.cpet.2014.06.002_bib148","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.radonc.2008.02.019","article-title":"18FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: a planning study","volume":"87","author":"van Loon","year":"2008","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.cpet.2014.06.002_bib149","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijrobp.2009.04.075","article-title":"Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study","volume":"77","author":"van Loon","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.cpet.2014.06.002_bib150","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11307-009-0227-y","article-title":"Early assessment of therapeutic response using FDG PET in small cell lung cancer","volume":"11","author":"Yamamoto","year":"2009","journal-title":"Mol Imaging Biol"},{"issue":"2","key":"10.1016\/j.cpet.2014.06.002_bib151","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3121\/cmr.2008.797","article-title":"Prognostic significance of 18 F-fluorodeoxyglucose - positron emission tomography after treatment in patients with limited stage small cell lung cancer","volume":"6","author":"Onitilo","year":"2008","journal-title":"Clin Med Res"},{"issue":"2","key":"10.1016\/j.cpet.2014.06.002_bib152","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.radonc.2011.03.014","article-title":"Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I-III small cell lung cancer: a hypothesis generating study","volume":"99","author":"van Loon","year":"2011","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.cpet.2014.06.002_bib153","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1055\/s-2008-1039314","article-title":"The role of positron emission tomography\/computed tomography in the diagnosis of pleural diseases","volume":"57","author":"Orki","year":"2009","journal-title":"Thorac Cardiovasc Surg"},{"issue":"12","key":"10.1016\/j.cpet.2014.06.002_bib154","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1097\/JTO.0b013e3181c0a7ff","article-title":"Clinical value of fluorodeoxyglucose-positron emission tomography\/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: an observational pilot study","volume":"4","author":"Yildirim","year":"2009","journal-title":"J\u00a0Thorac Oncol"},{"issue":"5","key":"10.1016\/j.cpet.2014.06.002_bib155","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11307-009-0212-5","article-title":"Potential of dual time point FDG-PET imaging in differentiating malignant from benign pleural disease","volume":"11","author":"Mavi","year":"2009","journal-title":"Mol Imaging Biol"},{"issue":"6","key":"10.1016\/j.cpet.2014.06.002_bib156","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jtcvs.2004.10.034","article-title":"Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: staging implications","volume":"129","author":"Erasmus","year":"2005","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"5","key":"10.1016\/j.cpet.2014.06.002_bib157","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.ejcts.2008.07.050","article-title":"Preoperative staging of mesothelioma by 18F-fluoro-2-deoxy-D-glucose positron emission tomography\/computed tomography fused imaging and mediastinoscopy compared to pathological findings after extrapleural pneumonectomy","volume":"34","author":"Sorensen","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"issue":"8","key":"10.1016\/j.cpet.2014.06.002_bib158","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.ejca.2012.01.016","article-title":"Relationship between 18F-FDG uptake on positron emission tomography and molecular biology in malignant pleural mesothelioma","volume":"48","author":"Kaira","year":"2012","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.cpet.2014.06.002_bib159","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jtcvs.2006.03.068","article-title":"Positron emission tomography predicts survival in malignant pleural mesothelioma","volume":"132","author":"Flores","year":"2006","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"9","key":"10.1016\/j.cpet.2014.06.002_bib160","first-page":"1233","article-title":"Relationship between 18 FDG PET-CT findings and the survival of 177 patients with malignant pleural mesothelioma","volume":"17","author":"Abakay","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"8","key":"10.1016\/j.cpet.2014.06.002_bib161","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1158\/1078-0432.CCR-09-2313","article-title":"A\u00a0novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parameters","volume":"16","author":"Nowak","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.cpet.2014.06.002_bib162","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s00259-013-2561-1","article-title":"The association of (18)F-FDG PET\/CT parameters with survival in malignant pleural mesothelioma","volume":"41","author":"Klabatsa","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"10.1016\/j.cpet.2014.06.002_bib163","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1245\/s10434-010-1107-z","article-title":"Volume-based parameter of (18)F-FDG PET\/CT in malignant pleural mesothelioma: prediction of therapeutic response and prognostic implications","volume":"17","author":"Lee","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.cpet.2014.06.002_bib164","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/annonc\/mds537","article-title":"Prognostic significance of metabolic response by positron emission tomography after neoadjuvant chemotherapy for resectable malignant pleural mesothelioma","volume":"24","author":"Tsutani","year":"2013","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.cpet.2014.06.002_bib165","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2967\/jnumed.107.042333","article-title":"Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans","volume":"48","author":"Francis","year":"2007","journal-title":"J\u00a0Nucl Med"},{"issue":"3","key":"10.1016\/j.cpet.2014.06.002_bib166","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.lungcan.2009.04.015","article-title":"Combined FDG-PET\/CT in response evaluation of malignant pleural mesothelioma","volume":"67","author":"Veit-Haibach","year":"2010","journal-title":"Lung Cancer"},{"issue":"5","key":"10.1016\/j.cpet.2014.06.002_bib167","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1007\/s00259-010-1704-x","article-title":"FDG PET\/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survival","volume":"38","author":"Gerbaudo","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"10.1016\/j.cpet.2014.06.002_bib168","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/MNM.0b013e3283653862","article-title":"Patterns of disease progression on 18F-fluorodeoxyglucose positron emission tomography-computed tomography in patients with malignant pleural mesothelioma undergoing multimodality therapy with pleurectomy\/decortication","volume":"34","author":"Bille","year":"2013","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.cpet.2014.06.002_bib169","unstructured":"Ettinger DS, Krug LM, Akerley W, et\u00a0al. NCCN Guidelines Version 1.2014 Malignant Pleural Mesothelioma. 2014. NCCN.org."},{"issue":"1","key":"10.1016\/j.cpet.2014.06.002_bib170","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.athoracsur.2013.02.069","article-title":"The society of thoracic surgeons guidelines on the diagnosis and staging of patients with esophageal cancer","volume":"96","author":"Varghese","year":"2013","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"10.1016\/j.cpet.2014.06.002_bib171","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.suronc.2013.02.003","article-title":"Meta-analysis of\u00a018FDG PET-CT for nodal staging in patients with esophageal cancer","volume":"22","author":"Shi","year":"2013","journal-title":"Surg Oncol"},{"key":"10.1016\/j.cpet.2014.06.002_bib172","article-title":"Diagnostic value of (18)F-FDG PET\/CT for lymph node metastasis of esophageal squamous cell carcinoma","author":"Yamada","year":"2013","journal-title":"Surg Today"},{"issue":"4","key":"10.1016\/j.cpet.2014.06.002_bib173","first-page":"857","article-title":"The additional value of integrated PET\/CT over PET in initial lymph node staging of esophageal cancer","volume":"20","author":"Kato","year":"2008","journal-title":"Oncol Rep"},{"issue":"8","key":"10.1016\/j.cpet.2014.06.002_bib174","first-page":"1255","article-title":"Additional value of PET\/CT over PET in assessment of locoregional lymph nodes in thoracic esophageal squamous cell cancer","volume":"47","author":"Yuan","year":"2006","journal-title":"J\u00a0Nucl Med"},{"issue":"2","key":"10.1016\/j.cpet.2014.06.002_bib175","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ejrad.2008.05.009","article-title":"Dual-time-point FDG PET for the evaluation of locoregional lymph nodes in thoracic esophageal squamous cell cancer","volume":"70","author":"Hu","year":"2009","journal-title":"Eur J Radiol"},{"issue":"6","key":"10.1016\/j.cpet.2014.06.002_bib176","doi-asserted-by":"crossref","first-page":"864","DOI":"10.2967\/jnumed.111.101568","article-title":"18F-FDG PET\/CT has a high impact on patient management and provides powerful prognostic stratification in the primary staging of esophageal cancer: a prospective study with mature survival data","volume":"53","author":"Barber","year":"2012","journal-title":"J\u00a0Nucl Med"},{"issue":"2","key":"10.1016\/j.cpet.2014.06.002_bib177","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00330-010-1943-z","article-title":"Additional benefit of (1)(8)F-fluorodeoxyglucose integrated positron emission tomography\/computed tomography in the staging of oesophageal cancer","volume":"21","author":"Gillies","year":"2011","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.cpet.2014.06.002_bib178","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s00259-008-0959-y","article-title":"Positron emission tomography changes management and prognostic stratification in patients with oesophageal cancer: results of a multicentre prospective study","volume":"36","author":"Chatterton","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1016\/j.cpet.2014.06.002_bib179","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/bjc.2013.478","article-title":"Evaluating the role of fluorodeoxyglucose positron emission tomography-computed tomography in multi-disciplinary team recommendations for oesophago-gastric cancer","volume":"109","author":"Blencowe","year":"2013","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.cpet.2014.06.002_bib180","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1245\/s10434-011-1928-4","article-title":"The impact of (1)(8)F-fluorodeoxyglucose positron emission tomography positive lymph nodes on postoperative recurrence and survival in resectable thoracic esophageal squamous cell carcinoma","volume":"19","author":"Yasuda","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.cpet.2014.06.002_bib181","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/bjs.7758","article-title":"Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma","volume":"99","author":"Gillies","year":"2012","journal-title":"Br J Surg"},{"issue":"6","key":"10.1016\/j.cpet.2014.06.002_bib182","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/jgh.12148","article-title":"Utility of baseline positron emission tomography with computed tomography for predicting endoscopic resectability and survival outcomes in patients with early esophageal adenocarcinoma","volume":"28","author":"Sun","year":"2013","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.cpet.2014.06.002_bib183","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/MNM.0000000000000046","article-title":"Pretreatment metabolic tumor volumes to predict the short-term outcome of unresectable locally advanced squamous cell carcinoma of the esophagus treated with definitive chemoradiotherapy","volume":"35","author":"Chen","year":"2014","journal-title":"Nucl Med Commun"},{"issue":"5","key":"10.1016\/j.cpet.2014.06.002_bib184","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/RLU.0b013e318238f703","article-title":"Predictive value of metabolic tumor volume measured by 18F-FDG PET for regional lymph node status in patients with esophageal cancer","volume":"37","author":"I","year":"2012","journal-title":"Clin Nucl Med"},{"issue":"1","key":"10.1016\/j.cpet.2014.06.002_bib185","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1245\/s10434-009-0719-7","article-title":"Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma","volume":"17","author":"Hyun","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.cpet.2014.06.002_bib186","first-page":"4163","article-title":"Use of pretreatment metabolic tumor volumes on PET-CT to predict the survival of patients with squamous cell carcinoma of esophagus treated by curative surgery","volume":"32","author":"Shum","year":"2012","journal-title":"Anticancer Res"},{"issue":"7","key":"10.1016\/j.cpet.2014.06.002_bib187","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00259-011-1755-7","article-title":"Prognostic value of 18F-FDG PET image-based parameters in oesophageal cancer and impact of tumour delineation methodology","volume":"38","author":"Hatt","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"10.1016\/j.cpet.2014.06.002_bib188","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ejca.2007.04.001","article-title":"Value of complete metabolic response by (18)F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy","volume":"43","author":"Kim","year":"2007","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.cpet.2014.06.002_bib189","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1245\/s10434-013-3343-5","article-title":"Determinants of response to neoadjuvant chemotherapy for esophageal cancer using 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET)","volume":"21","author":"Miyata","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.cpet.2014.06.002_bib190","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1002\/bjs.9253","article-title":"Relevance of [18F]fluorodeoxyglucose positron emission tomography-positive lymph nodes after neoadjuvant chemotherapy for squamous cell oesophageal cancer","volume":"100","author":"Miyata","year":"2013","journal-title":"Br J Surg"},{"issue":"9","key":"10.1016\/j.cpet.2014.06.002_bib191","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1470-2045(07)70244-9","article-title":"PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial","volume":"8","author":"Lordick","year":"2007","journal-title":"Lancet Oncol"},{"issue":"1017","key":"10.1016\/j.cpet.2014.06.002_bib192","doi-asserted-by":"crossref","first-page":"e694","DOI":"10.1259\/bjr\/29946900","article-title":"Prognostic significance of SUV on PET\/CT in patients with localised oesophagogastric junction cancer receiving neoadjuvant chemotherapy\/chemoradiation: a systematic review and meta-analysis","volume":"85","author":"Zhu","year":"2012","journal-title":"Br J Radiol"},{"issue":"4","key":"10.1016\/j.cpet.2014.06.002_bib193","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00259-012-2325-3","article-title":"Evaluation of early response to concomitant chemoradiotherapy by interim 18F-FDG PET\/CT imaging in patients with locally advanced oesophageal carcinomas","volume":"40","author":"Cuenca","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.cpet.2014.06.002_bib194","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.radonc.2008.06.014","article-title":"Adenocarcinomas of the esophagus: response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET-CT. Comparison to histopathologic and clinical response evaluation","volume":"89","author":"Roedl","year":"2008","journal-title":"Radiother Oncol"},{"issue":"8","key":"10.1016\/j.cpet.2014.06.002_bib195","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.2967\/jnumed.106.036509","article-title":"Diagnostic and prognostic value of 18F-FDG PET\/CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus","volume":"48","author":"Guo","year":"2007","journal-title":"J\u00a0Nucl Med"},{"issue":"2","key":"10.1016\/j.cpet.2014.06.002_bib196","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s10147-010-0044-y","article-title":"(18)F-fluorodeoxyglucose positron emission tomography immediately after chemoradiotherapy predicts prognosis in patients with locoregional postoperative recurrent esophageal cancer","volume":"15","author":"Jingu","year":"2010","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.cpet.2014.06.002_bib197","unstructured":"Ajani JA, Bentrem DJ, Besh S, et\u00a0al. NCCN guidelines version 2.2013. Esophageal and esophagogastric junction cancers. 2013. NCCN.org."},{"issue":"5","key":"10.1016\/j.cpet.2014.06.002_bib198","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/01243894-200606000-00016","article-title":"Preoperative chemo-radiation-induced ulceration in patients with esophageal cancer: a confounding factor in tumor response assessment in integrated computed tomographic-positron emission tomographic imaging","volume":"1","author":"Erasmus","year":"2006","journal-title":"J\u00a0Thorac Oncol"},{"issue":"7 Suppl 3","key":"10.1016\/j.cpet.2014.06.002_bib199","doi-asserted-by":"crossref","first-page":"S1710","DOI":"10.1097\/JTO.0b013e31821e8cff","article-title":"The Masaoka-Koga stage classification for thymic malignancies: clarification and definition of terms","volume":"6","author":"Detterbeck","year":"2011","journal-title":"J\u00a0Thorac Oncol"},{"issue":"10 Suppl 4","key":"10.1016\/j.cpet.2014.06.002_bib200","doi-asserted-by":"crossref","first-page":"S304","DOI":"10.1097\/JTO.0b013e3181f20c05","article-title":"Staging system of thymoma","volume":"5","author":"Masaoka","year":"2010","journal-title":"J\u00a0Thorac Oncol"},{"issue":"4","key":"10.1016\/j.cpet.2014.06.002_bib201","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.athoracsur.2003.07.042","article-title":"WHO histologic classification is a prognostic indicator in thymoma","volume":"77","author":"Kondo","year":"2004","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"10.1016\/j.cpet.2014.06.002_bib202","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1309\/AJCP76KEGWQKWOKA","article-title":"Thymomas I: a clinicopathologic correlation of 250 cases with emphasis on the World Health Organization schema","volume":"137","author":"Moran","year":"2012","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.cpet.2014.06.002_bib203","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.ejcts.2007.01.024","article-title":"Role of fluorine-18 fluorodeoxyglucose positron emission tomography in thymic pathology","volume":"31","author":"El-Bawab","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"issue":"23","key":"10.1016\/j.cpet.2014.06.002_bib204","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1200\/JCO.2009.27.4662","article-title":"Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors","volume":"28","author":"Kaira","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.cpet.2014.06.002_bib205","first-page":"1628","article-title":"18F-FDG PET\/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups","volume":"47","author":"Sung","year":"2006","journal-title":"J\u00a0Nucl Med"},{"issue":"3","key":"10.1016\/j.cpet.2014.06.002_bib206","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s12149-014-0804-2","article-title":"18F-fluorodeoxyglucose positron emission tomography for evaluation of thymic epithelial tumors: utility for World Health Organization classification and predicting recurrence-free survival","volume":"28","author":"Seki","year":"2014","journal-title":"Ann Nucl Med"},{"issue":"2","key":"10.1016\/j.cpet.2014.06.002_bib207","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1093\/ejcts\/ezt263","volume":"44","author":"Toba","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"issue":"2","key":"10.1016\/j.cpet.2014.06.002_bib208","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.lungcan.2013.08.003","article-title":"Role of combined 18F-FDG-PET\/CT for predicting the WHO malignancy grade of thymic epithelial tumors: a multicenter analysis","volume":"82","author":"Lococo","year":"2013","journal-title":"Lung Cancer"},{"issue":"3\u20134","key":"10.1016\/j.cpet.2014.06.002_bib209","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2152\/jmi.59.225","article-title":"The utility of FDG-PET in the diagnosis of thymic epithelial tumors","volume":"59","author":"Otsuka","year":"2012","journal-title":"J\u00a0Med Invest"},{"issue":"8","key":"10.1016\/j.cpet.2014.06.002_bib210","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00259-009-1082-4","article-title":"(18)F-FDG PET for the evaluation of thymic epithelial tumors: correlation with the World Health Organization classification in addition to dual-time-point imaging","volume":"36","author":"Inoue","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1016\/j.cpet.2014.06.002_bib211","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1158\/1078-0432.CCR-12-2929","article-title":"18F-fluorodeoxyglucose positron emission tomography in the management of patients with thymic epithelial tumors","volume":"19","author":"Thomas","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.cpet.2014.06.002_bib212","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s12149-010-0455-x","article-title":"18F-FDG uptake on PET helps predict outcome and response after treatment in unresectable thymic epithelial tumors","volume":"25","author":"Kaira","year":"2011","journal-title":"Ann Nucl Med"},{"issue":"4","key":"10.1016\/j.cpet.2014.06.002_bib213","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1510\/icvts.2010.236273","article-title":"Clinical use of combined positron emission tomography and computed tomography in thymoma recurrence","volume":"11","author":"El-Bawab","year":"2010","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.cpet.2014.06.002_bib214","unstructured":"Ettinger DS, Riely GJ, Akerley W, et\u00a0al. NCCN guidelines version 1.2014. Thymomas and thymic carcinomas. 2014. NCCN.org."}],"container-title":["PET Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859814000650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859814000650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,23]],"date-time":"2020-08-23T00:42:38Z","timestamp":1598143358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556859814000650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":214,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S1556859814000650"],"URL":"https:\/\/doi.org\/10.1016\/j.cpet.2014.06.002","relation":{},"ISSN":["1556-8598"],"issn-type":[{"value":"1556-8598","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[18F]Fluorodeoxyglucose PET in Thoracic Malignancies","name":"articletitle","label":"Article Title"},{"value":"PET Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpet.2014.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}